Summit Trail Advisors’s Opko Health OPK Stock Holding History

Summit Trail Advisors’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-351	Closed	-$2K	–	1287
2017 Q4	$2K	Buy	+351	New	+$2.04K	﹤0.01%	1664

Other funds holding OPK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MSL

Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Summit Trail Advisors's OPK Position: Q1 2018 in Review

Summit Trail Advisors sold out of Opko Health (OPK) in Q1 2018, closing a stake of 351 shares — an estimated $2K sold.

Summit Trail Advisors first reported a position in OPK in Q4 2017 and held it in 1 quarter. The position peaked at $2K in Q4 2017. 227 funds tracked by Wall St. Rank hold OPK as of Q1 2018.

Summit Trail Advisors reported no remaining Opko Health position as of Q1 2018 after selling out during the quarter.
Summit Trail Advisors sold 351 Opko Health shares in Q1 2018, an estimated $2K.
Summit Trail Advisors first reported a position in Opko Health in Q4 2017 and held it in 1 quarter.
Summit Trail Advisors's Opko Health position peaked at $2K in Q4 2017.
227 funds tracked by Wall St. Rank held Opko Health as of Q1 2018.

Based on Summit Trail Advisors's 13F filing for Q1 2018, filed 21 May 2018.